Skip to main content
Keymed Biosciences Inc. logo

Keymed Biosciences Inc. — Investor Relations & Filings

Ticker · 2162 LEI · 549300600S6M6SOT7P36 HKEX Manufacturing
Open in API
Filings indexed 774 across all filing types
Latest filing 2025-12-05 Interim / Quarterly Rep…
Country KY Cayman Islands
Listing HKEX 2162

About Keymed Biosciences Inc.

http://www.keymedbio.com

Keymed Biosciences Inc. is a biopharmaceutical company specializing in the in-house discovery and development of innovative biological therapies. The company focuses on therapeutic areas with urgent unmet clinical needs, primarily autoimmune diseases, other chronic conditions, and oncology. Keymed operates an integrated, full-chain platform covering source innovation, clinical development, production, and commercialization. It maintains a diversified and globally competitive product pipeline, leveraging its advanced R&D engine and cGMP-compliant manufacturing capabilities to deliver high-quality, affordable treatments.

Recent filings

Filing Released Lang Actions
Interim Report 2025/26
Interim / Quarterly Report Classification · 1% confidence The document is titled 'INTERIM REPORT 2025/2026' for Suga International Holdings Limited. It contains comprehensive financial statements, including the Condensed Consolidated Interim Balance Sheet, Income Statement, and Cash Flow Statement, as well as management discussion and analysis for the six-month period ended 30 September 2025. This aligns perfectly with the definition of an Interim/Quarterly Report (IR). H1 2025
2025-12-05 English
Letter and Reply Form to Non-registered Shareholders - Notice of Publication of Interim Report 2025/26 and Arrangement of Electronic Dissemination of Corporate Communications
Report Publication Announcement Classification · 1% confidence The document is a notification letter sent to non-registered shareholders regarding the publication of the company's Interim Report 2025/26. It provides instructions on how to access the report electronically and how to request a printed copy. It does not contain the actual financial report itself, but rather serves as an announcement of its availability. Following the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2025-12-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025
Regulatory Filings Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies in Hong Kong to report monthly movements in securities, including share capital, issued shares, and treasury shares. Since it is a recurring regulatory filing regarding share capital and securities movements that does not fit into specific categories like 'Share Issue' (which usually implies a specific event) or 'Transaction in Own Shares' (which is for specific buybacks), it is best classified as a general Regulatory Filing.
2025-12-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025
Share Issue/Capital Change Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies in Hong Kong to report monthly movements in securities, including share capital, issued shares, and treasury shares. Since it details changes in share capital and securities, it falls under the category of share issues and capital changes.
2025-12-01 English
Cash Dividend Announcement for Equity Issuer
Notice of Dividend Amount Classification · 1% confidence The document is a formal announcement from Suga International Holdings Limited regarding a cash dividend declaration. While the title mentions 'Announcement of Unaudited Interim Results', the content is structured as a standard dividend declaration form (EF001) for the Hong Kong Stock Exchange, detailing dividend amounts, ex-dividend dates, and payment dates. According to the filing definitions, an announcement of dividend amounts and payment details is classified as 'DIV'.
2025-11-26 English
ANNOUNCEMENT OF UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025
Interim / Quarterly Report Classification · 1% confidence The document is titled 'ANNOUNCEMENT OF UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025' and contains comprehensive financial statements, including the income statement, balance sheet, and segment information. It is not a mere announcement of a report, but the report itself, containing substantive financial data for an interim period. Therefore, it is classified as an Interim/Quarterly Report. H1 2025
2025-11-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.